Form 4: Castle Biosciences Executive Tobin Juvenal Exercises Options and Sells Shares

Tobin W. Juvenal, Chief Commercial Officer of Castle Biosciences, exercised stock options and sold shares of common stock on November 1, 2024, according to a Form 4 filing with the SEC.

Summary

• On November 1, 2024, Tobin W. Juvenal, the Chief Commercial Officer of Castle Biosciences, exercised stock options to acquire 1,100 shares of common stock at a price of $3.38 per share.
• Simultaneously, Juvenal sold 3,100 shares of common stock at a weighted-average price of $35.39 per share, with individual trades ranging from $35.38 to $35.42.
• These transactions were executed under a pre-arranged Rule 10b5-1 trading plan adopted on March 10, 2024.
• Following these transactions, Juvenal directly owns 54,178 shares of Castle Biosciences common stock and indirectly owns 2,230 shares through the Tobin W and Susan M Juvenal Family Revocable Trust.
• He also holds options for 20,110 shares.

Sentiment

Score: 5

Explanation: The sentiment is neutral as it simply reports transactions. The executive is selling a small portion of their holdings, which could be for personal financial planning reasons.

Industry Context

Executive stock transactions are a common occurrence in publicly traded companies and are often scrutinized by investors for insights into management's perspective on the company's future prospects.

Key Dates